Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR

MLA

Gülistan Karadeniz, et al. “Which One Is Superior in Predicting 30 and 90 Days Mortality after COPD Exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR.” Expert Review of Respiratory Medicine, vol. 15, Mar. 2021, pp. 845–51. EBSCOhost, https://doi.org/10.1080/17476348.2021.1901584.

APA

Gülistan Karadeniz, Mine Gayaf, Filiz Güldaval, Merve Satir Turk, & Gülru Polat. (2021). Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR. Expert Review of Respiratory Medicine, 15, 845–851. https://doi.org/10.1080/17476348.2021.1901584

Chicago

Gülistan Karadeniz, Mine Gayaf, Filiz Güldaval, Merve Satir Turk, and Gülru Polat. 2021. “Which One Is Superior in Predicting 30 and 90 Days Mortality after COPD Exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR.” Expert Review of Respiratory Medicine 15 (March): 845–51. doi:10.1080/17476348.2021.1901584.